Partnership established between Fiocruz and the Government of the State of Paraná, through the Institute of Technology of Paraná (TECPAR).
Foundation of the Molecular Biology Institute of Paraná (IBMP).
Signing of the Scientific Cooperation Agreement between IBMP, Fiocruz, Hemobrás and Tecpar for the implementation of the NAT in the Brazilian blood donation network, with the objective of preventing transmission of HIV and HCV (hepatitis C) viruses.
Approval of the project of installation of Fiocruz Paraná on the Tecpar campus, within the existing facilities in use by IBMP.
Creation of the INCT Health.
Completion of Plant for Development and Production of Diagnostics Products. Fiocruz Paraná is inaugurated.
IBMP is certified in Good Manufacturing Practices by ANVISA (Brazilian National Agency of Sanitary Surveillance).
IBMP receives a technology demand from the Ministry of Health and commences the Pregnancy care Project, with funding from FINEP.
IBMP receives technology demand from the Ministry of Health and commences the Sepsis Project, with funding from FINEP.
IBMP launches the Microarray Project, with funding from BNDES.
Ministerial Directive no. 2.712, of 12th of November of 2013, determines as compulsory the use of the HIV/HVC NAT Kit in public and private blood centers in Brazil.
IBMP includes the molecular test for detecting HBV (hepatitis B virus) in the NAT Kit.
IBMP launches the Neglected Diseases Project, with funding from BNDES.
The Unified National Health System (SUS) requires a diagnostic kit that provides differential diagnosis of zika, dengue and chikungunya viruses. IBMP begins to produce the amplification modules for diagnosis of each of these diseases.